‌

US Patent 8216567 Therapeutic ribonucleases

Patent 8216567 was granted and assigned to Quintessence Biosciences on July, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Quintessence Biosciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8216567

Patent Inventor Names

Laura Strong0

Tony Klink0

John Kink0

Date of Patent

July 10, 2012

Patent Application Number

13231050

Date Filed

September 13, 2011

Patent Primary Examiner

‌

Tekchand Saidha

Patent abstract

The present invention relates to the use of ribonucleases (RNases) in the treatment or prevention of disease.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8216567 Therapeutic ribonucleases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API